Iverjohn-12 – Ivermectin 12 mg Tablets
Iverjohn-12 is labeled as containing Ivermectin USP 12 mg in each tablet. Ivermectin is an antiparasitic medicine with established medical uses for certain infections involving susceptible parasites. The displayed Iverjohn-12 product carries Johnlee branding and is supplied in a 10 × 10 tablet pack.
Active Ingredient
Ivermectin USP 12 mg
According to the product labeling, each Iverjohn-12 tablet contains Ivermectin USP 12 mg together with the excipients used in the formulation.
Medicine Information
Oral ivermectin has established medical uses for certain parasitic infections. Current United States prescribing information includes intestinal strongyloidiasis caused by Strongyloides stercoralis and onchocerciasis caused by Onchocerca volvulus among the approved indications for oral ivermectin.
Ivermectin acts against susceptible parasites by interfering with nerve and muscle functions that are important for their survival.
The appropriate ivermectin treatment depends on factors including the particular infection, the patient's body weight, medical history, other medicines being taken, and individual clinical circumstances.
The 12 mg strength displayed on Iverjohn-12 does not mean that one tablet is the appropriate dose for every patient or parasitic infection. Ivermectin treatment is determined by body weight and the condition being treated.
The fact that ivermectin has established prescription uses in the United States does not establish that the Iverjohn-12 brand or its 12 mg tablet is a U.S.-approved drug product.
How to Use
Use Iverjohn-12 only under appropriate guidance from a healthcare professional. The amount of ivermectin and treatment schedule can vary according to the infection being treated and the patient's body weight.
Do not determine how many tablets to take solely from the 12 mg strength printed on the packaging.
Do not increase the dose, repeat treatment, or use Iverjohn-12 for another suspected parasitic infection without appropriate professional guidance.
Important Safety Information
Before using ivermectin, tell your healthcare professional about medical conditions, allergies, prescription medicines, non-prescription products, and supplements that you currently use.
Pregnancy, breastfeeding, liver-related conditions, and other relevant medical circumstances should be discussed with a healthcare professional before ivermectin is used.
Ivermectin can cause adverse effects in some individuals. Seek appropriate medical assistance for a severe, persistent, unusual, or concerning reaction.
A suspected parasitic infection should be properly evaluated because different parasites may require different medicines or approaches to treatment.
Antiparasitic Medicine Use
Iverjohn-12 should be used only when ivermectin is considered appropriate for the particular parasitic infection.
Symptoms similar to a previous parasitic infection do not necessarily indicate the same infection. Do not use another person's prescription or follow a treatment programme intended for somebody else.
Do not substitute veterinary ivermectin products for medicines formulated for human use.
Product Authenticity Information
Regulatory authorities have previously identified counterfeit Iverjohn-12 products in overseas online supply channels. In a safety alert published in 2025, Australia's Therapeutic Goods Administration reported that tested imported Iverjohn-12 samples contained less ivermectin than the stated 12 mg amount.
That regulatory finding concerned the samples tested by the authority and does not by itself establish the authenticity or composition of every package bearing the Iverjohn-12 name. Product identity, batch details, packaging, and supply-chain documentation should therefore be appropriately verified.
Storage and Handling
Keep Iverjohn-12 in its original packaging and follow the storage instructions provided with the medicine. Protect the product from unsuitable storage conditions and keep it out of the reach of children.
Brand Information
Iverjohn-12 is labeled as containing Ivermectin USP 12 mg per tablet. The displayed product carries Johnlee branding and is supplied in a 10 × 10 tablet pack.
Important Notice
The information provided on this page is intended for general product awareness and should not replace diagnosis, a prescription, professional medical advice, treatment, monitoring, or the official information supplied with the medicine. Approved indications, available strengths, dosage schedules, warnings, and regulatory requirements may differ between countries. Follow the instructions of an appropriately qualified healthcare professional.
Reviews
Write Your Own Review